Astrazeneca Pharma India Ltd ASTRAZEN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/05/21 IST
3,457.60quote price arrow down-41.25 (-1.18%)
Volume
14,730
52 week range
1,885.00 - 4,970.00

...

Loading . . .

KEY STATS

  • Open3,498.00
  • Day High3,502.90
  • Day Low3,450.00
  • Prev Close3,498.85
  • 52 Week High4,970.00
  • 52 Week High Date09/08/20
  • 52 Week Low1,885.00
  • 52 Week Low Date03/23/20
  • Market Cap1,182.5M
  • Shares Out25M
  • 10 Day Average Volume24,088.09
  • Dividend2.00
  • Dividend Yield0.06%
  • Beta
  • 1 Year % Change31.47

RATIOS/PROFITABILITY

  • EPS (TTM)30.24
  • P/E (TTM)114.33
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/20/2020
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest Astrazeneca Pharma India Ltd News

There is no recent news for this security.

Latest ASTRAZEN-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture and sale of pharmaceutical products. The Clinical Trial...
Darius Udwadia Esq.
Non-Executive Chairman
Rajesh Marwaha
Chief Financial Officer
Address
Ni 12Th Floor, Manyata Empassy Business
Park Rachenahalli,Outer Ring Rd Kr Puram
Hebbal
Bangalore
560045
India